16 results on '"Ogbomo, Adesuwa"'
Search Results
2. Real‐world study on the characteristics, post‐nephrectomy journey, and outcomes of patients with early‐stage renal cell carcinoma based on risk groups.
3. sj-docx-1-tam-10.1177_17588359231182386 – Supplemental material for Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)
4. Vulnerability to extreme-heat-associated hospitalization in three counties in Michigan, USA, 2000–2009
5. Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb).
6. Disease-free and overall survival outcomes for localized RCC patients by disease stage.
7. The direct and indirect health care costs associated with pulmonary arterial hypertension among commercially insured patients in the United States
8. Real-world outcomes among patients with metastatic colorectal cancer treated first line with bevacizumab-awwb.
9. Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis
10. Comparative effectiveness of endothelin receptor antagonists on mortality in patients with pulmonary arterial hypertension in a US Medicare population: a retrospective database analysis
11. A descriptive analysis of real-world treatment patterns of innovator (Remicade®) and biosimilar infliximab in an infliximab-naïve Turkish population
12. Analysis of real-world treatment patterns in a matched rheumatology population that continued innovator infliximab therapy or switched to biosimilar infliximab
13. Vulnerability to extreme-heat-associated hospitalization in three counties in Michigan, USA, 2000–2009
14. A descriptive analysis of real-world treatment patterns of innovator (Remicade®) and biosimilar infliximab in an infliximab-naïve Turkish population.
15. Analysis of real-world treatment patterns in a matched rheumatology population that continued innovator infliximab therapy or switched to biosimilar infliximab.
16. A descriptive analysis of real-world treatment patterns of innovator (Remicade ® ) and biosimilar infliximab in an infliximab-naïve Turkish population.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.